The Lifelong Burden of Homozygous Familial Hypercholesterolemia

Area of Science:

• Cardiovascular Genetics
• Metabolic Disorders
• Pharmacology

Background:

• Homozygous familial hypercholesterolemia (HoFH) results from low-density lipoprotein receptor gene mutations.
• HoFH presents in youth with xanthomas and severe hypercholesterolemia.
• Untreated HoFH leads to early coronary artery disease and reduced lifespan.

Observation:

• A case of HoFH was managed with standard and experimental treatments.
• Atherosclerosis progressed across all vascular beds despite aggressive interventions.
• The patient survived until age 59, longer than typically expected without intervention.

Findings:

• Aggressive therapies did not halt the progression of atherosclerosis in this HoFH patient.
• The patient experienced a prolonged but ultimately fatal course of the disease.
• This case underscores the challenges in managing advanced HoFH.

Implications:

• Early diagnosis and consistent, appropriate follow-up are crucial for HoFH management.
• Novel therapeutic strategies are needed to effectively manage HoFH and its complications.
• Understanding HoFH progression informs future research and clinical practice for severe hypercholesterolemia.